Literature DB >> 12086261

Pathogenic mechanisms in giant cell arteritis.

Cornelia M Weyand1, Jörg J Goronzy.   

Abstract

T lymphocytes, encountering stimulatory signals in the adventitia of medium-size arteries, emerge as the key players in inflammation-associated injury pathways. In GCA, all injury mechanisms have been related to effector macrophages. Regulated by IFN-gamma-producing T cells, macrophages commit to distinct avenues of differentiation and acquire a spectrum of potentially harmful capabilities (Figure 1). Macrophages in the adventitia focus on production of pro-inflammatory cytokines. Macrophages in the media specialize in oxidative damage with lipid peroxidation attacking smooth muscle cells and matrix components. These macrophages also supply reactive oxygen intermediates that, in combination with nitrogen intermediates, cause protein nitration of endothelial cells. Production of oxygen radicals is complemented by the production of metalloproteinases, likely essential in the breakdown of elastic membranes. With the fragmentation of the internal elastic lamina, the intimal layer becomes accessible to migratory myofibroblasts that, driven by PDGF, form a hyperplastic intimal layer and cause occlusion of the vessel lumen. Expansion of the hyperplastic intima is accompanied by intense neoangiogenesis, supported by angiogenesis factors that again derive from specialized macrophages. Similarities in injury pathways between GCA and another arterial disease, atherosclerosis, are beginning to be recognized. Specifically, activated T cells and macrophages are increasingly appreciated as key players in the process of instability and rupture of atherosclerotic plaque. A specialized subset of CD4 T cells, CD4+ CD28- T cells, are suspected to participate in tissue injury in the plaque. These T cells are equipped with cytolytic capabilities and release large amounts of IFN-gamma. Comparative studies between patients with GCA and those with acute coronary syndromes should enhance our ability to define the principles of arterial wall inflammation, the specifics of injury in that microenvironment, and help in the identification of the eliciting signals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086261     DOI: 10.3949/ccjm.69.suppl_2.sii28

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  8 in total

1.  Sudden cardiac death caused by coronary vasculitis.

Authors:  Katsuya Norita; Sofia V de Noronha; Mary N Sheppard
Journal:  Virchows Arch       Date:  2012-02-04       Impact factor: 4.064

2.  [Vertebrobasilar ischemia as a complication of temporal arteritis. Results of a prospective, clinical, ultrasonographic study].

Authors:  K Pfadenhauer; M Esser; H Weber; K D Wölfle
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  Giant cell arteritis and cardiovascular disease in older adults.

Authors:  J G Ray; M M Mamdani; W H Geerts
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 4.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

Review 5.  Giant Cell Arteritis: Beyond Corticosteroids.

Authors:  Lauren Steel; Asad Khan; Bhaskar Dasgupta
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

Review 6.  Granulomatous vasculitis.

Authors:  Javier Marquez; Diana Flores; Liliana Candia; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

Review 7.  Notch Signaling Regulation in Autoinflammatory Diseases.

Authors:  Rossella Gratton; Paola Maura Tricarico; Adamo Pio d'Adamo; Anna Monica Bianco; Ronald Moura; Almerinda Agrelli; Lucas Brandão; Luisa Zupin; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 8.  A Review of the Dermatological Complications of Giant Cell Arteritis.

Authors:  Diana Prieto-Peña; Santos Castañeda; Belén Atienza-Mateo; Ricardo Blanco; Miguel Ángel González-Gay
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.